Revenue fell 58.0% year over year to $2.1 million in Q2 2025, missing estimates by more than 50 %. - Earnings per share loss was $(1.24) for Q2 2025, narrower than expected. Ekso Bionics (NASDAQ:EKSO) ...

Exclusive: Australians are being warned of the risk of cut-price overseas plastic surgeries which are leaving many deformed ...

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ('Ekso Bionics” or the 'Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the ...

Total joint replacements have transformed millions of lives, but their success demands rigorous assessment of long-term safety, durability, and performance.

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial ...

This study provides novel and convincing evidence that both dopamine D1 and D2 expressing neurons in the nucleus accumbens shell are crucial for the expression of cue-guided action selection, a ...

The South Park franchise, created by Trey Parker and Matt Stone, blew the roof off adult animation when they released this ...

Antalya is known not only for its touristic beauties but also for its world-class health services. Finding the right clinic is of great importance ...

Faith in the possibility of 'enhancing' humankind – the extension human abilities and lifespan by any technological means – ...

The 'Piano Man' artist had to cancel his upcoming 2025 concerts due to a concerning diagnosis. Learn all about it here.

This research introduces musculoskeletal robots using programmable lattices, enhancing robotic flexibility and strength ...

Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) ...